Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
A simple ask in 2016: the UN goal of universal HIV treatment

Last week, the working draft for 2016 UN Political Declaration on HIV/AIDS was released with only a few days for comments. Called the Zero draft, like previous statements produced every five years, it is a list of observations, comments and goals. But using the UN Statement as a platform of human rights has become disconnected from the scientific and medical advances in HIV over the last five years. The bulk of the draft document could have been written at any time during the epidemic, certainly most of it could have been written in 2011. There is only one reference to dramatic changes in the WHO 2015 guidelines and only two references to PrEP.

Published
7 hours ago
From
i-Base
Namibia: Over 144 000 On ARV Treatment

Close to 144 000 people are on antiretroviral (ARV) treatment countrywide, according to the latest statistics released by the Ministry of Health and Social Services.

Published
26 April 2016
From
AllAfrica
New York Insurers to Change Coverage of Hepatitis C Drugs

Seven health-insurance companies in New York will change their criteria for covering costly drugs that cure chronic hepatitis C under the terms of agreements with the office of State Attorney General Eric Schneiderman.

Published
26 April 2016
From
Wall Street Journal
HIV PrEP currently too pricey to justify use in people who inject drugs

The model suggested that over 20 years, enrolling a quarter of HIV uninfected injection drug users in a PrEP + screening + ART program would be the optimal approach for reducing HIV infection. However, at current drug prices this approach would cost the U.S. an additional $44 billion, which is equivalent to annually spending 10 percent of the current federal budget for domestic HIV/AIDS on PrEP for people who inject drugs.

Published
26 April 2016
From
Medical Xpress
Opt-out HIV testing in a hospital emergency department may cost less than managing two patients with undiagnosed HIV

Opt-out HIV testing in accident and emergency departments in areas of high HIV prevalence is likely to save NHS trusts money by avoiding expensive in-patient admissions for

Published
26 April 2016
By
Roger Pebody
European Commission Grants Marketing Authorization for Gilead’s Fixed-Dose Combination Descovy® (Emtricitabine, Tenofovir Alafenamide) for Treatment of HIV

Gilead Sciences, Inc. today announced that the European Commission has granted marketing authorization for two doses of Descovy® (emtricitabine and tenofovir alafenamide 200/10 mg and 200/25 mg; F/TAF), a fixed-dose combination for the treatment of HIV-1 infection. Descovy is Gilead’s second TAF-based therapy to receive marketing authorization in the European Union.

Published
25 April 2016
From
Gilead press release
ViiV Healthcare, Medicines Patent Pool Extend Licence for Dolutegravir to All Lower Middle-Income Countries

The Medicines Patent Pool (MPP) and ViiV Healthcare announced an extension of their current licensing agreement today to increase access to dolutegravir (DTG), a promising new antiretroviral, to cover all remaining lower middle-income countries. The amendment to the 2014 licence specifically allows generic medicine distribution in four countries with patents - Armenia, Moldova, Morocco and Ukraine - that were not covered in the initial agreement. MPP sub-licensees can now sell in countries that are home to 94% of people living with HIV in the developing world.

Published
25 April 2016
From
ViiV Healthcare press release
This Pill Prevents HIV—But It's Treated Like An Illicit Drug

Around the world, people have to jump through hoops, and sometimes break laws, just to get it.

Published
23 April 2016
From
Vocativ
How Can We Help Young People Under Age 18 Get PrEP?

Getting PrEP into the hands of young people at high risk for HIV infection is a priority that experts are now discussing. A recent webinar and Q&A session hosted by HIVE brought together PrEP providers from across the country to talk about some of these issues and share successes and challenges.

Published
22 April 2016
From
BETA blog
Multiple social and health factors associated with irregular attendance at London HIV clinics

People who miss appointments for HIV care are more likely to have money problems, childcare responsibilities and a history of depression according to a recent UK study. While

Published
22 April 2016
By
Roger Pebody
← First12345...540Next →

Filter by country